BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10583316)

  • 21. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins.
    Apter D; Bützow TL; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1993 Apr; 76(4):940-9. PubMed ID: 8473410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.
    Bergendahl M; Aloi JA; Iranmanesh A; Mulligan TM; Veldhuis JD
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression and recovery of LH secretion by a potent and selective GnRH-receptor antagonist peptide in healthy early follicular-phase women are mediated via selective control of LH secretory burst mass.
    Gianotti L; Veldhuis JD; Destefanis S; Lanfranco F; Ramunni J; Arvat E; Marzetto M; Boutignon F; Deghenghi R; Ghigo E
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):526-32. PubMed ID: 14510918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of changing gonadotropin-releasing hormone pulse frequency on puberty.
    Bridges NA; Hindmarsh PC; Matthews DR; Brook CG
    J Clin Endocrinol Metab; 1994 Sep; 79(3):841-7. PubMed ID: 8077371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment.
    Armeanu MC; Berkhout GM; Schoemaker J
    Fertil Steril; 1992 Apr; 57(4):762-70. PubMed ID: 1555686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of antagonists of dopamine and opiates on the basal and GnRH-induced secretion of luteinizing hormone, follicle stimulating hormone and prolactin during lactational amenorrhoea in breastfeeding women.
    Tay CC; Glasier AF; McNeilly AS
    Hum Reprod; 1993 Apr; 8(4):532-9. PubMed ID: 8501180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of opioid blockade and GnRH administration upon luteinizing hormone secretion in patients with anorexia nervosa during the stages of weight loss and weight recovery.
    García-Rubí E; Vazquez-Alemán D; Mendez JP; Salinas JL; Garza-Flores J; Ponce-de-León S; Perez-Palacios G; Ulloa-Aguirre A
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):520-8. PubMed ID: 1286522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease in gonadotropin-releasing hormone (GnRH) pulse frequency with aging in postmenopausal women.
    Hall JE; Lavoie HB; Marsh EE; Martin KA
    J Clin Endocrinol Metab; 2000 May; 85(5):1794-800. PubMed ID: 10843154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulsatile gonadotrophin secretion in hyperprolactinaemic amenorrhoea an the response to bromocriptine therapy.
    Moult PJ; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1982 Feb; 16(2):153-62. PubMed ID: 6802531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
    Berga SL; Yen SS
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults.
    Aimaretti G; Colao A; Corneli G; Pivonello R; MacCario M; Morrison K; Pflaum CD; Strasburger CJ; Lombardi G; Ghigo E
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):771-7. PubMed ID: 10619983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Luteinizing hormone responses to luteinizing hormone releasing hormone, and growth hormone and cortisol responses to insulin induced hypoglycaemia in functional secondary amenorrhoea.
    Hirvonen E; Seppälä M; Karonen SL; Adlercreutz H
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):225-36. PubMed ID: 319613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary responsiveness after administration of a GnRH agonist depot formulation: Decapeptyl CR.
    Broekmans FJ; Bernardus RE; Broeders A; Berkhout G; Schoemaker J
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):579-87. PubMed ID: 8334744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of pulsatile gonadotropin secretion by testosterone in man.
    Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 1984 Apr; 58(4):609-14. PubMed ID: 6421864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The frequency of pulsatile luteinizing hormone-releasing hormone treatment and luteinizing hormone and follicle-stimulating hormone secretion in women with amenorrhea of suprapituitary origin.
    Lambalk CB; Schoemaker J; van Rees GP; van Dieten HA
    Fertil Steril; 1989 Mar; 51(3):416-22. PubMed ID: 2493401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influences on quality of life in GH deficient adults and their effect on response to treatment.
    Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estradiol supplementation in postmenopausal women attenuates suppression of pulsatile growth hormone secretion by recombinant human insulin-like growth factor type I.
    Veldhuis JD; Keenan DM; Bailey JN; Adeniji A; Miles JM; Paulo R; Cosma M; Soares-Welch C
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4471-8. PubMed ID: 18728158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.